Balyasny Asset Management L.P. Takes Position in Larimar Therapeutics, Inc. (NASDAQ:LRMR)
Balyasny Asset Management L.P. purchased a new position in Larimar Therapeutics, Inc. (NASDAQ:LRMR – Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 79,496 shares of the company’s stock, valued at approximately $308,000. Balyasny Asset Management L.P. owned about 0.12% of […]
More Stories
Why Some Doctors Are Turning Against Vaccine Mandates
By Zachary Stieber For Dr. Anish Koka, vaccine mandates made sense. He has a daughter who received an organ transplant,...
Wall Street Review: Stocks End Week Mixed Amid Bulls-Bears Tug of War
By Panos Mourdoukoutas Equities finished the week mixed as a renewed tug-of-war played out between bullish investors focused on the...
Voting Under Fire: Zelenskyy Weighs Elections in Ukraine, but Wartime Obstacles Remain
By Chris Summers Ukrainian President Volodymyr Zelenskyy said on Dec. 9 he was prepared to hold elections within three months...
Suspect in Taiwan’s Deadly Knife Attack Acted Alone, Police Say
By T.J. Muscaro The man suspected of killing at least three people with a knife and discharging smokebombs in Taipei,...
Trump Reveals 50 State Tour to Celebrate America’s 250th Birthday
By Jacki Thrapp President Donald Trump has announced the U.S. 250 Freedom Tour to celebrate America’s 250th birthday. The tour,...
DOJ Seeking Appeals on Dismissals of Criminal Cases Against James Comey, Letitia James
By Troy Myers The U.S. Department of Justice (DOJ) is appealing the dismissal of a pair of criminal cases against...